---
figid: PMC5708962__medi-96-e8725-g005
figlink: /pmc/articles/PMC5708962/figure/F5/
number: F5
caption: Mechanism of action of VEGFA/VEGFR2 pathway on the formation of MA. TKI = tyrosine
  kinase inhibitor, VEGFA = vascular endothelial growth factor A, VEGFR2 = vascular
  endothelial growth factor receptor 2.
pmcid: PMC5708962
papertitle: Apatinib concurrent gemcitabine for controlling malignant ascites in advanced
  pancreatic cancer patient.
reftext: Lijun Liang, et al. Medicine (Baltimore). 2017 Nov;96(47):e8725.
pmc_ranked_result_index: '129107'
pathway_score: 0.5735924
filename: medi-96-e8725-g005.jpg
figtitle: Mechanism of action of VEGFA/VEGFR2 pathway on the formation of MA
year: '2017'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5708962__medi-96-e8725-g005.html
  '@type': Dataset
  description: Mechanism of action of VEGFA/VEGFR2 pathway on the formation of MA.
    TKI = tyrosine kinase inhibitor, VEGFA = vascular endothelial growth factor A,
    VEGFR2 = vascular endothelial growth factor receptor 2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RASA1
  - KDR
  - VEGFA
genes:
- word: gaps
  symbol: GAP
  source: hgnc_alias_symbol
  hgnc_symbol: RASA1
  entrez: '5921'
- word: VEGFR2
  symbol: VEGFR2
  source: hgnc_alias_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: VEGFA/VEGFR2
  symbol: VEGFA
  source: hgnc_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
chemicals: []
diseases: []
figid_alias: PMC5708962__F5
redirect_from: /figures/PMC5708962__F5
figtype: Figure
---
